ESOPHAGEAL AND/OR CARDIA CANCER

Clinical trials for ESOPHAGEAL AND/OR CARDIA CANCER explained in plain language.

Never miss a new study

Get alerted when new ESOPHAGEAL AND/OR CARDIA CANCER trials appear

Sign up with your email to follow new studies for ESOPHAGEAL AND/OR CARDIA CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New cancer drug candidate HLX18 faces off against OPDIVO in early trial

Disease control Not yet recruiting

This early-stage study tests whether a new drug called HLX18 works like the approved cancer drug OPDIVO. About 174 adults with esophageal cancer, melanoma, or bladder cancer who had surgery to remove their tumors will receive either HLX18 or OPDIVO. The main goal is to compare ho…

Matched conditions: ESOPHAGEAL AND/OR CARDIA CANCER

Phase: PHASE1 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control

Last updated May 15, 2026 11:57 UTC

ESOPHAGEAL AND/OR CARDIA CANCER

Get alerted when new ESOPHAGEAL AND/OR CARDIA CANCER trials appear

New cancer drug candidate HLX18 faces off against OPDIVO in early trial